Yumanity Therapeutics

-$0.20 (-2.16%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell YMTX and other ETFs, options, and stocks.

About YMTX

Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform.

CEO
Richard Peters
Employees
44
Headquarters
Boston, Massachusetts
Founded
2014

YMTX Key Statistics

Market Cap
93.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
105.11K
High Today
$9.41
Low Today
$8.84
Open Price
$9.26
Volume
89.17K
52 Week High
$23.47
52 Week Low
$8.21

YMTX Earnings

-$1.03
-$0.69
-$0.34
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure